Product
Dysport
Name
Dysport
INN Name
Botulinum Toxin Type A
FDA Approved
Yes
4 clinical trials
1 organization
6 indications
1 document
Indication
SpasticityIndication
Moderate to Severe Upper Face LinesIndication
RosaceaIndication
Botulinum ToxinsIndication
Type AIndication
HerniaClinical trial
An Integrated Phase I/II, Multicentre, Double-blind, Randomised, Dysport and Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in the Treatment of Adult Upper Limb Spasticity.Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
A Phase Ib/II, Multicentre, Double-blind, Randomised, Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in Improving the Appearance of Moderate to Severe Upper Facial Lines in AdultsStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
The Effects of Preoperative Botulinum Toxin A Injection Prior to Abdominal Wall Reconstruction Procedures on Respiratory System FunctionStatus: Recruiting, Estimated PCD: 2024-09-01
Document
DailyMed Label: DysportOrganization
Ipsen Biopharmaceuticals, Inc.